This inventor holds 9 USPTO granted patents. Top assignees: Ajinomoto Co., Ltd., Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, Banyu Pharmaceutical Co. Ltd. Active years: 1978-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yokohama, JP (1978 - 1989)
- Nagoya, JP (1994)
Company Filing History:
4 out of 1,953 
3 out of 212 
2 out of 237 Years Active: 1978-1994
Title: Toshiharu Nagatsu: A Pioneer in Pharmaceutical Innovation
Introduction:
Toshiharu Nagatsu, a renowned inventor hailing from Yokohama, Japan, has left an indelible mark in the world of pharmaceutical innovation through his relentless pursuit of creating groundbreaking compounds for therapeutic use. With a total of 9 patents to his name, Nagatsu's commitment to advancing medical science is truly commendable.
Latest Patents:
Nagatsu's latest patents include the development of N-methylphenylserine alkyl ester derivatives and their uses in treating disorders related to adrenergic functions. These compounds show promise in stimulating the central nervous system's adrenergic functions, offering potential therapeutic benefits for various conditions. Additionally, his work on threo-adrenalinecarboxylic acid presents new avenues for treating Parkinson's disease and mental depression.
Career Highlights:
Throughout his illustrious career, Toshiharu Nagatsu has displayed a remarkable dedication to innovation in the field of pharmaceuticals. His role in companies such as Ajinomoto Co., Ltd. and the Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai has been instrumental in driving forward research and development efforts in drug discovery.
Collaborations:
Nagatsu has had the privilege of working alongside esteemed colleagues such as Hamao Umezawa and Tomio Takeuchi, whose contributions have further enriched the landscape of pharmaceutical research. Together, they have pioneered new methodologies and compounds that have the potential to revolutionize the treatment of various diseases.
Conclusion:
In conclusion, Toshiharu Nagatsu's contributions to pharmaceutical innovation underscore his status as a true pioneer in the field. His passion for creating novel compounds with therapeutic benefits showcases a deep-seated commitment to improving the quality of life for individuals around the world. Nagatsu's legacy serves as an inspiration for future inventors and innovators seeking to make a positive impact on healthcare and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile